Margaret A. Horn's most recent trade in Revolution Medicines Inc was a trade of 4,583 Common Stock done at an average price of $99.5 . Disclosure was reported to the exchange on March 17, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 99.48 per share. | 17 Mar 2026 | 4,583 | 157,570 (0%) | 0% | 99.5 | 455,919 | Common Stock |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 100.02 per share. | 07 Jan 2026 | 53,096 | 162,957 (0%) | 0% | 100.0 | 5,310,471 | Common Stock |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 51,406 | 1,094 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.45 per share. | 07 Jan 2026 | 51,406 | 192,459 (0%) | 0% | 42.5 | 2,182,185 | Common Stock |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 23,594 | 119,906 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.80 per share. | 07 Jan 2026 | 23,594 | 216,053 (0%) | 0% | 29.8 | 703,101 | Common Stock |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 101.79 per share. | 07 Jan 2026 | 20,204 | 142,753 (0%) | 0% | 101.8 | 2,056,622 | Common Stock |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 102.90 per share. | 07 Jan 2026 | 1,700 | 141,053 (0%) | 0% | 102.9 | 174,930 | Common Stock |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 76.82 per share. | 16 Dec 2025 | 4,847 | 141,053 (0%) | 0% | 76.8 | 372,333 | Common Stock |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 45.82 per share. | 16 Sep 2025 | 4,775 | 145,900 (0%) | 0% | 45.8 | 218,814 | Common Stock |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 39.83 per share. | 16 Jun 2025 | 3,510 | 150,675 (0%) | 0% | 39.8 | 139,803 | Common Stock |
| Sangamo Therapeutics Inc | Margaret A. Horn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Sangamo Therapeutics Inc | Margaret A. Horn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 25,000 | 82,650 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 39.04 per share. | 17 Mar 2025 | 3,058 | 153,533 (0%) | 0% | 39.0 | 119,385 | Common Stock |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 100,100 | 100,100 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 28,600 | 156,591 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | A. Horn Margaret | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 45.40 per share. | 16 Dec 2024 | 4,329 | 127,991 (0%) | 0% | 45.4 | 196,553 | Common Stock |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 50.34 per share. | 11 Oct 2024 | 50,000 | 132,320 (0%) | 0% | 50.3 | 2,517,055 | Common Stock |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Oct 2024 | 44,631 | 0 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.09 per share. | 11 Oct 2024 | 44,631 | 176,951 (0%) | 0% | 4.1 | 182,541 | Common Stock |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.09 per share. | 11 Oct 2024 | 5,369 | 182,320 (0%) | 0% | 4.1 | 21,959 | Common Stock |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Oct 2024 | 5,369 | 97,382 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 44.19 per share. | 16 Sep 2024 | 4,331 | 132,320 (0%) | 0% | 44.2 | 191,367 | Common Stock |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 37.39 per share. | 17 Jun 2024 | 4,415 | 136,651 (0%) | 0% | 37.4 | 165,064 | Common Stock |
| Sangamo Therapeutics Inc | Margaret A. Horn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Sangamo Therapeutics Inc | Margaret A. Horn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 25,000 | 57,650 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 31.58 per share. | 18 Mar 2024 | 2,914 | 139,553 (0%) | 0% | 31.6 | 92,033 | Common Stock |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.09 per share. | 11 Mar 2024 | 15,735 | 158,202 (0%) | 0% | 4.1 | 64,356 | Common Stock |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2024 | 15,735 | 52,567 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 34.02 per share. | 11 Mar 2024 | 15,735 | 142,467 (0%) | 0% | 34.0 | 535,306 | Common Stock |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2024 | 7,936 | 44,631 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 34.07 per share. | 11 Mar 2024 | 7,936 | 142,467 (0%) | 0% | 34.1 | 270,345 | Common Stock |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.09 per share. | 11 Mar 2024 | 7,936 | 150,403 (0%) | 0% | 4.1 | 32,458 | Common Stock |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 143,500 | 143,500 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 41,000 | 142,467 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Margaret Horn A. | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.09 per share. | 15 Dec 2023 | 5,000 | 109,460 (0%) | 0% | 4.1 | 20,450 | Common Stock |
| Revolution Medicines Inc | A. Margaret Horn | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 5,000 | 68,302 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Margaret Horn A. | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 26.64 per share. | 15 Dec 2023 | 5,000 | 104,460 (0%) | 0% | 26.6 | 133,183 | Common Stock |
| Revolution Medicines Inc | A. Margaret Horn | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 25.90 per share. | 15 Dec 2023 | 2,993 | 101,467 (0%) | 0% | 25.9 | 77,524 | Common Stock |
| Revolution Medicines Inc | Horn A. Margaret | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.09 per share. | 06 Dec 2023 | 5,000 | 109,460 (0%) | 0% | 4.1 | 20,450 | Common Stock |
| Revolution Medicines Inc | A. Margaret Horn | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2023 | 5,000 | 73,302 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | A. Horn Margaret | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 06 Dec 2023 | 5,000 | 104,460 (0%) | 0% | 25 | 125,000 | Common Stock |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.09 per share. | 31 Aug 2023 | 10,000 | 109,474 (0%) | 0% | 4.1 | 40,900 | Common Stock |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2023 | 10,000 | 108,302 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 34.05 per share. | 31 Aug 2023 | 10,000 | 99,474 (0%) | 0% | 34.0 | 340,458 | Common Stock |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.09 per share. | 15 Aug 2023 | 5,000 | 104,474 (0%) | 0% | 4.1 | 20,450 | Common Stock |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 5,000 | 118,302 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 30.36 per share. | 15 Aug 2023 | 3,085 | 101,389 (0%) | 0% | 30.4 | 93,652 | Common Stock |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 30.80 per share. | 15 Aug 2023 | 1,915 | 99,474 (0%) | 0% | 30.8 | 58,981 | Common Stock |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 24.89 per share. | 20 Jun 2023 | 2,102 | 99,474 (0%) | 0% | 24.9 | 52,321 | Common Stock |
| Sangamo Therapeutics Inc | Margaret A. Horn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 27,750 | 27,750 | - | - | Stock Option (Right to Buy) | |
| Sangamo Therapeutics Inc | Margaret A. Horn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 13,900 | 32,650 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Margaret A. Horn | See Remarks | Sale of securities on an exchange or to another person at price $ 21.78 per share. | 17 Mar 2023 | 1,230 | 100,062 (0%) | 0% | 21.8 | 26,789 | Common Stock |
| Revolution Medicines Inc | Margaret A. Horn | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 140,000 | 140,000 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Margaret A. Horn | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 40,000 | 101,292 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Margaret A. Horn | See Remarks | Sale of securities on an exchange or to another person at price $ 22.94 per share. | 19 Dec 2022 | 1,220 | 61,292 (0%) | 0% | 22.9 | 27,985 | Common Stock |
| Sangamo Therapeutics Inc | Margaret A. Horn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2022 | 37,500 | 37,500 | - | - | Stock Option (Right to Buy) | |
| Sangamo Therapeutics Inc | Margaret A. Horn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2022 | 18,750 | 18,750 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 20.15 per share. | 07 Nov 2022 | 17,767 | 0 (0%) | 0% | 20.2 | 358,069 | Common Stock |
| Revolution Medicines Inc | Margaret A. Horn | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 20.41 per share. | 31 Oct 2022 | 17,767 | 17,767 (0%) | 0% | 20.4 | 362,541 | Common Stock |
| Revolution Medicines Inc | Margaret A. Horn | See Remarks | Sale of securities on an exchange or to another person at price $ 20.15 per share. | 26 Oct 2022 | 17,768 | 35,534 (0%) | 0% | 20.1 | 357,968 | Common Stock |
| Revolution Medicines Inc | Margaret A. Horn | See Remarks | Sale of securities on an exchange or to another person at price $ 19.04 per share. | 19 Sep 2022 | 1,267 | 62,512 (0%) | 0% | 19.0 | 24,127 | Common Stock |
| Revolution Medicines Inc | Margaret A. Horn | See Remarks | Sale of securities on an exchange or to another person at price $ 17.75 per share. | 17 Jun 2022 | 1,145 | 63,779 (0%) | 0% | 17.7 | 20,323 | Common Stock |
| Revolution Medicines Inc | Margaret A. Horn | See Remarks | Sale of securities on an exchange or to another person at price $ 18.61 per share. | 17 Mar 2022 | 321 | 63,987 (0%) | 0% | 18.6 | 5,975 | Common Stock |
| Revolution Medicines Inc | Margaret A. Horn | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 135,800 | 135,800 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Margaret A. Horn | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 38,800 | 64,308 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Margaret A. Horn | See Remarks | Sale of securities on an exchange or to another person at price $ 30.02 per share. | 17 Sep 2021 | 479 | 25,999 (0%) | 0% | 30.0 | 14,380 | Common Stock |
| Revolution Medicines Inc | Margaret A. Horn | See Remarks | Sale of securities on an exchange or to another person at price $ 34.13 per share. | 17 Jun 2021 | 464 | 26,478 (0%) | 0% | 34.1 | 15,835 | Common Stock |